Advertisement
Infectious Disease
Subscribe to Infectious Disease
View Sample

FREE Email Newsletter

8 Questions About the Recovered U.S. Ebola Patients

August 22, 2014 8:30 am | by Mike Stobbe - AP Medical Writer - Associated Press | News | Comments

Two American aid workers have recovered from Ebola and left an Atlanta hospital, after weeks of intensive treatment in a special isolation unit. They were first two Ebola patients ever brought to the United States.           

Combining Vaccines Boosts Polio Immunity

August 22, 2014 8:22 am | by Lauran Neergaard - AP Medical Writer - Associated Press | News | Comments

New research suggests a one-two punch could help battle polio in some of the world's most remote and strife-torn regions: Giving a single vaccine shot to children who've already swallowed drops of an oral polio vaccine greatly boosted their immunity.

TB Likely Spread with Help from Seals, Sea Lions

August 21, 2014 10:34 am | News | Comments

Scientists who study tuberculosis have long debated its origins. New research shows that tuberculosis likely spread from humans in Africa to seals and sea lions that brought the disease to South America and transmitted it to Native people there before Europeans landed on the continent.

Advertisement

Both American Ebola Patients Discharged from Hospital

August 21, 2014 8:22 am | by Jeff Martin and Katie Foody - Associated Press - Associated Press | News | Comments

After nearly three weeks of treatment, the two American aid workers who were infected with the deadly Ebola virus in Africa have been discharged from an Atlanta hospital, officials said Thursday.               

Enzyme Holds the Door for Influenza

August 20, 2014 12:47 pm | News | Comments

The enzyme phospholipase D (PLD) helps the influenza virus escape the immune response, and blocking it could lead to a new way to prevent the flu.                             

Breakthrough in the Fight Against Drug-resistant Superbugs

August 19, 2014 11:51 am | News | Comments

Scientists have made a breakthrough in the fight against the most resistant hospital superbugs by developing the first innovative antibacterial gel that acts to kill Pseudomonas aeruginosa, staphylococci and E. coli, using natural proteins.     

Ebola Has Killed More Than 1,200, WHO Says

August 19, 2014 6:19 am | by The Associated Press | News | Comments

The U.N. health agency says the Ebola outbreak in West Africa has now killed more than 1,200 people. The World Health Organization says the death toll has risen to 1,229 from among the 2,240 reported cases in Guinea, Liberia, Nigeria and Sierra Leone. 

Can Twitter Help Better Identify Foodborne Illness Cases?

August 18, 2014 12:33 pm | News | Comments

An estimated 55 million to 105 million people in the United States suffer from foodborne illnesses each year, according to the CDC, resulting in costs of $2 to $4 billion annually. What if Twitter could be used to track those cases and more quickly identify the source of the problem?

Advertisement

Antibiotics in Early Life May Alter Long-term Immunity

August 18, 2014 11:34 am | News | Comments

New research found that receiving antibiotic treatments early in life can increase susceptibility to specific diseases later on. The study helps scientists understand how different antibiotics affect good bacteria.        

Another Ebola Problem: Finding Its Natural Source

August 17, 2014 9:17 am | by Mike Stobbe and Marilynn Marchione - AP Medical Writers - Associated Press | News | Comments

A scary problem lurks beyond the frenzied efforts to keep people from spreading Ebola: No one knows exactly where the virus comes from or how to stop it from seeding new outbreaks.                    

CDC Scientist Kept Quiet About Flu Blunder

August 15, 2014 12:21 pm | by Mike Stobbe - AP Medical Writer - Associated Press | News | Comments

An investigation into a potentially dangerous blunder at a government lab found that a scientist kept silent about the accident and revealed it only after other employees noticed something fishy.               

Ebola Puts Focus on Drugs Made in Tobacco Plants

August 15, 2014 2:22 am | by Malcolm Ritter - AP Science Writer - Associated Press | News | Comments

It's an eye-catching angle in the story of an experimental treatment for Ebola: The drug comes from tobacco plants that were turned into living pharmaceutical factories. Using plants this way — sometimes called "pharming" — can produce complex and valuable proteins for medicines.

NewLink Genetics: Ready to Test Ebola Vaccine

August 14, 2014 10:22 am | by The Associated Press | News | Comments

An Iowa drug developer says it has enough doses of a possible vaccine for the deadly Ebola virus to launch an initial round of human testing. NewLink Genetics Chief Financial Officer Gordon Link says the timing of the trials is uncertain, but the company is receiving help from a number of sources to speed up the process.

Advertisement

Sierra Leone: Another Top Doctor Dies from Ebola

August 13, 2014 9:21 am | by Clarence Roy-Macaulay and Maria Cheng - Associted Press - Associted Press | News | Comments

A leading physician in Sierra Leone's fight against Ebola has died from the disease, an official said Wednesday, as it emerged that another top doctor had been considered to receive an experimental drug but did not get it and later died.    

An Easier Way to Manipulate Malaria Genes

August 12, 2014 2:06 pm | News | Comments

Plasmodium falciparum, the parasite that causes malaria, has proven notoriously resistant to scientists’ efforts to study its genetics. It can take up to a year to determine the function of a single gene, which has slowed efforts to develop new, more targeted drugs and vaccines.

Priest Dies of Ebola; UN Debates Treatment Ethics

August 12, 2014 8:21 am | by Maria Cheng and Ciaran Giles - Associated Press - Associated Press | News | Comments

A Spanish missionary priest being treated for Ebola died Tuesday in a Madrid hospital amid a worldwide debate over who should get experimental Ebola treatments. After holding a teleconference with medical experts around the world, the WHO declared it is ethical to use unproven Ebola drugs and vaccines in the current outbreak.

Like Cling Wrap, New Biomaterial Can Coat Burn Wounds and Block Infection

August 11, 2014 2:01 pm | News | Comments

Wrapping wound dressings around fingers and toes can be tricky, but for burn victims, guarding them against infection is critical. Today, scientists are reporting the development of novel, ultrathin coatings called nanosheets that can cling to the body’s most difficult-to-protect contours and keep bacteria at bay.

WHO: Ebola Outbreak is a Public Health Emergency

August 8, 2014 3:21 am | by Maria Cheng - AP Medical Writer - Associated Press | News | Comments

The World Health Organization on Friday declared the Ebola outbreak in West Africa to be an international public health emergency that requires an extraordinary response to stop its spread. The WHO announced the Ebola outbreak — the largest and longest in history — is worrying enough to merit being declared an international health emergency. WHO declared similar emergencies for the swine flu pandemic in 2009 and for polio in May.

FDA Warns of Infection-causing Tattoo Inks

August 7, 2014 3:23 am | by Mary Clare Jalonick - Associated Press - Associated Press | News | Comments

Thinking about getting inked? Check the bottle first. The Food and Drug Administration is warning tattoo parlors, their customers and those buying at-home tattoo kits that not all tattoo ink is safe.               

Creating New Immune Systems for HIV Patients

August 5, 2014 2:52 pm | by Cynthia Fox | Blogs | Comments

There is good news in attempts to halt HIV by growing, in patients, new immune systems lacking a gene that led to the first—and only—cured HIV patient. Using hematopoietic (blood) stem cells possessing a CCR5 gene mutation that blocks CD4 T cell entry of HIV, Calimmune—led by Nobel Laureate David Baltimore—has, for one year, safely begun growing new immune systems in patients.

Study Predicts Hepatitis C Will Become a Rare Disease in 22 Years

August 5, 2014 2:06 pm | News | Comments

Effective new drugs and screening would make hepatitis C a rare disease by 2036, according to a computer simulation conducted by The University of Texas MD Anderson Cancer Center and the University of Pittsburgh Graduate School of Public Health.

Obesity Paradox in Survival from Sepsis

August 5, 2014 1:51 pm | News | Comments

University of Michigan Health System researchers revealed an obesity paradox among older Americans suffering from sepsis. In a study of 1,404 Medicare beneficiaries, heavier patients were more likely to survive the life-threatening infection that can lead to a stay in a hospital’s intensive care unit.

Smart Bacteria Help Each Other Survive

August 5, 2014 1:47 pm | News | Comments

The body’s assailants are cleverer than previously thought. New research from Lund University in Sweden shows for the first time how bacteria in the airways can help each other replenish vital iron. The bacteria thereby increase their chances of survival, which can happen at the expense of the person’s health.

Toledo Mayor Lifts Water Ban

August 4, 2014 10:22 am | by John Seewer - Associated Press - Associated Press | News | Comments

A water ban that had hundreds of thousands of people in Ohio and Michigan scrambling for drinking water has been lifted, Toledo's mayor announced Monday.                           

Ebola Vaccine Not Far Away

August 4, 2014 9:22 am | by The Associated Press | News | Comments

The nation's top infectious disease official says there's hope that a vaccine against Ebola will be available as early as next July. Dr. Anthony Fauci of the National Institutes of Health says such a preventive vaccine has been successfully tested with monkeys.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading